CytoDyn and Biomm have signed an exclusive supply and distribution agreement to market leronlimab in Brazil on receiving regulatory approval.
- CytoDyn and Biomm enter leronlimab supply agreement – Pharmaceutical Technology
- CytoDyn’s chief scientific officer Rahman quietly exits amid leronlimab limbo – FierceBiotech